15231 Video of Translational Research in Surgical Oncology: From Regional Therapy to Oncolytic Viral Immunotherapy (October 28, 2015)
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Professionals:
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.
General Surgeons, Physician Assistants, Allied Health Care Professionals
1) To develop an understanding of the importance of translational research and its impact on finding better treatments for cancer.
2) To learn the appropriate indications for regional therapy for peritoneal and liver metastases.
3) To learn the most updated data regarding oncolytic viral immunotherapy and its use as a novel therapeutic agent.
David L. Bartlett, MD
Bernard Fisher Professor of Surgery, Vice Chair, Gastrointestinal and Surgical Oncology Services Director, Koch Center for Regional Therapy University of Pittsburgh UPMC Health System
All persons in control of content have NO relevant financial relationships to disclose.
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.
- 1.00 MOC Part IIMOC Part II credit.